Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.
Science (New York, N.Y.)|January 5, 2013
A strategy for modulation of enzymes in the ubiquitin systemAndreas Ernst, George Avvakumov, Jiefei Tong, et al.
Cell|July 11, 2020
A Genetic Map of the Response to DNA Damage in Human CellsMichele Olivieri, Tiffany Cho, Alejandro Álvarez-Quilón, et al.
Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.
Nature|July 20, 2018
The shieldin complex mediates 53BP1-dependent DNA repairSylvie M Noordermeer, Salomé Adam, Dheva Setiaputra, et al.
Nature|April 21, 2022
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibitionDavid Gallo, Jordan T F Young, Jimmy Fourtounis, et al.
Nature Communications|February 6, 2019
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovaryYibo Xue, Brian Meehan, Elizabeth Macdonald, et al.
Nature Genetics|September 3, 2024
In vivo CRISPR screens identify a dual function of MEN1 in regulating tumor-microenvironment interactionsPeiran Su, Yin Liu, Tianyi Chen, et al.
JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Pageof 15